ArticleAlzheimer's & dementia (New York, N. Y.)

Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation.

Maansi Barnwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.